If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEco Animal Regulatory News (EAH)

Share Price Information for Eco Animal (EAH)

Share Price is delayed by 15 minutes
Get Live Data
91.00    0.00 (0.00%)
Bid:
90.00
Ask:
92.00
Spread: 2.00 (2.222%)
Market Cap: £60.38m
EAH Live PriceLast checked at - London Stock Exchange

Intraday Eco Animal Share Chart

Directorate change

22 Aug 2019 07:00

 

ECO Animal Health Group plc (‘’ECO”)

(AIM: EAH)

Directorate Change

ECO Animal Health Group plc (the “Group”) announces that Richard Wood is stepping down as Non-executive Chairman and will be leaving the board of the Company with immediate effect.

Since joining Richard has successfully implemented significant changes including reshaping the board and its processes.

The board will now commence a search for a new chairman.

Following Richard’s departure and whilst the board seeks to appoint a permanent replacement, Andrew Jones, the Senior Non-executive director, will act as interim Chairman.

Marc Loomes, CEO of ECO, commented “I would like to thank Richard for his significant contribution and wish him well for the future”

Enquiries:

ECO Animal Health Group plc

Andrew Jones

Marc Loomes

Tel:

07771 903917

020 84478899

N+1 Singer (Nominated Adviser and Joint Broker)

Mark Taylor

James White

Tel: 020 7496 3000

Peel Hunt (Joint Broker)

James Steel

Dr Christopher Golden

Tel: 020 7418 8900

IFC Advisory

Graham Herring

Miles Nolan

Tel: 020 3934 6637

About ECO Animal Health Ltd

ECO Animal Health based in London U.K. is a leader in the development, registration and marketing of pharmaceutical products for global animal health markets. Its products for these growth markets promote well-being in animals and include the novel antimicrobial, Aivlosin®, as well as a range of generic therapeutic products.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190821005615/en/

Copyright Business Wire 2019

Date   Source Headline
9th Oct 20247:00 amRNSIssue of Equity and TVR
1st Oct 20247:00 amRNSTrading Update
27th Sep 20242:21 pmRNSResult of AGM
30th Aug 20243:07 pmRNSDirector/PDMR Shareholding
29th Aug 20247:00 amRNSDeferred Share Option Award to Executive Directors
23rd Aug 20241:18 pmRNSHolding(s) in Company
16th Aug 20247:00 amRNSPosting of the Annual Report and Notice of AGM
12th Aug 20241:30 pmRNSBlock Listing Interim Review
15th Jul 20247:00 amRNSFinal Results
11th Jul 20249:30 amRNSNotice of Results
8th May 20247:00 amRNSRisk Profile Demonstrated for ECOVAXXIN MS
25th Apr 20247:00 amRNSTrading Update on year ended 31 March 2024
8th Apr 20247:00 amRNSHolding(s) in Company
4th Apr 20247:00 amRNSDisposal of non-core product line
22nd Mar 20247:00 amRNSShare Awards to Executive Directors
21st Mar 20249:13 amRNSReplacement: Trading Update
21st Mar 20247:00 amRNSTrading Update
19th Mar 20249:40 amRNSGeneral Meeting Result
27th Feb 20247:00 amRNSPublication of Notice of General Meeting
6th Feb 20247:00 amRNSTrademark Approval for ECOVAXXIN® family in the EU
8th Jan 20247:00 amRNSDisposal of Freehold Properties
5th Jan 20245:05 pmRNSHolding(s) in Company
5th Jan 20245:00 pmRNSHolding(s) in Company
22nd Dec 20237:00 amRNSDeferred Option Awards to Executive Directors
1st Dec 20237:00 amRNSDirector/PDMR Shareholding
27th Nov 202310:00 amRNSInvestor Presentation
27th Nov 20237:00 amRNSResults for the six months ended 30 September 2023
14th Nov 20233:00 pmRNSHolding(s) in Company
9th Nov 20237:00 amRNSCapital Markets Day Events
24th Oct 20237:00 amRNSNew USA and Canada label claim for Aivlosin®
28th Sep 20237:00 amRNSESG Rating
7th Sep 20232:57 pmRNSResult of AGM
10th Aug 20237:00 amRNSNotice of AGM
21st Jul 20234:25 pmRNSPosting of the Annual Report and Accounts
10th Jul 20237:00 amRNSFinal Results for the Year Ended 31 March 2023
5th Jul 20237:00 amRNSNotice of Results & Investor Presentation
6th Jun 20237:00 amRNSIssue of Equity and Total Voting Rights
18th May 20237:00 amRNSHolding(s) in Company
23rd Mar 20237:00 amRNSTrading Update
8th Mar 20237:00 amRNSAnimal Health Innovation Summit
27th Feb 202310:37 amRNSDirector/PDMR Shareholding
24th Feb 20233:19 pmRNSChange of Registered Address
17th Feb 20231:41 pmRNSHolding(s) in Company
13th Feb 20231:55 pmRNSHolding(s) in Company
9th Feb 20237:00 amRNSHolding(s) in Company
9th Feb 20237:00 amRNSHolding(s) in Company
8th Feb 20237:00 amRNSDirector/PDMR Shareholding
20th Jan 202312:14 pmRNSHolding(s) in Company
13th Dec 20223:50 pmRNSDeferred Share Option Awards
30th Nov 20223:01 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.